KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer CellsYulin Lin(National Taiwan University), Ann‐Lii Cheng(National Taiwan University)PLoS ONENovember 28, 201210.1371/journal.pone.0050701Cited by 48SaveCiteExport RISWatch citationsRelated PapersVertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin|Molecular Cancer|2014|46Novel Insights of Lymphomagenesis of Helicobacter pylori-Dependent Gastric Mucosa-Associated Lymphoid Tissue Lymphoma|Cancers|2019|42